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S U M M A R Y
Background: Leishmaniasis is one of the neglected infectious diseases of the world. This disease largely
affects individuals of low socio-economic level, mainly in developing countries.
Methods: The aim of this study was to investigate the cumulative number of cases, case fatality rate, and
trend in incidence and mortality rate of visceral leishmaniasis (VL) in Eastern Sudan. A retrospective
descriptive study was performed through analysis of the database managed by the Ministry of Health in
Gadarif State, which includes all cases of VL.
Results: Over the 14-year study period (2002–2015), a total of 51 773 patients were registered in Gadarif
State with clinical and laboratory evidence of proven VL. The trend in VL was considerably higher over
the years 2003–2005 as compared to the last 5 years of 2011–2015. The highest fatality rate was
observed in 2002 (4.8%) and it had declined in 2014 (1.1%) and 2015 (1.7%). Rural residence was
statistically associated with death related to VL (p = 0.021).
Conclusions: This study showed a high number of cumulative cases of VL in Eastern Sudan. The fatality
rate was found to be highest among rural residents and has declined in the last 5 years. Thus immediate
interventions are needed in terms of health education and the implementation of preventive measures,
with a speciﬁc focus on people residing in rural areas.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Leishmaniasis is one of the neglected infectious diseases of
the world. It largely affects individuals of low socio-economic
level, mainly in developing countries.1–3 Clinically, the disease is
characterized by a diverse spectrum of manifestations that develop
after infection with protozoan parasites of the genus
Leishmania. Features of the disease vary widely, but are often
divided into three distinct clinical syndromes, namely visceral
leishmaniasis (VL)/kala-azar with its dermatological sequelae (post
kala-azar dermal leishmaniasis, PKDL), cutaneous leishmaniasis
(CL), and mucosal leishmaniasis (ML).4 VL places a huge burden on
society in terms of morbidity, mortality, and economic burden.
Worldwide, more than 90% of VL cases occur in six countries:
Bangladesh, Brazil, Ethiopia, India, South Sudan, and Sudan.1,4* Corresponding author. Tel.: +249 912351175; fax: +249 411823501.
E-mail address: abuzianab73@yahoo.com (A.A. Ali).
http://dx.doi.org/10.1016/j.ijid.2016.08.021
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).VL is a disseminated protozoan infection, transmitted by sand
ﬂy bites, in which macrophages of the liver, spleen, and bone
marrow are preferentially parasitized with intracellular replica-
tion.5 Leishmania donovani is the primary cause of VL in Sudan and
East Africa.6 Epidemiological and entomological studies have
conﬁrmed Phlebotomus orientalis to be the vector in several parts of
Sudan, typically associated with Acacia seyal and Balanites
aegyptiaca vegetation.7
In Sudan, VL is primarily anthroponotic.8 Sudan has a
population of 36.4 million, VL is endemic in seven states and
17 localities, and all clinical forms exist (VL, PKDL, CL, ML). During
the period 2002–2011, a total of 29 700 cases were reported, with a
case fatality rate of 3.7%.8,9 Gadarif State in Sudan is highly
endemic for VL, thus the current study was performed to
investigate the cumulative number of cases, case fatality rate,
and the trend in incidence and mortality rate of VL, with the aim of
providing program managers with the fundamental data necessary
for interventions and the implementation of a strategic plan to
reduce the incidence rate of this disease in Sudan.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Cumulative number of cases, new cases, and case fatality rate of visceral
leishmaniasis in Gadarif State, Eastern Sudan—2002–2015
Year New cases Cumulative cases Deaths Case fatality rate
2002 4006 - 192 4.8%
2003 7304 11 310 228 3.1%
2004 7004 18 314 264 3.8%
2005 4138 22 452 186 4.5%
2006 2792 25 244 109 3.9%
2007 2751 27 995 98 3.5%
2008 3277 31 272 89 2.7%
2009 4097 35 369 143 3.5%
2010 5050 40 419 142 2.8%
2011 2660 43 079 73 1.4%
2012 2022 45 101 45 2.2%
2013 1897 46 51 2.6%
2014 2818 49 31 1.1%
2015 1957 51 773 35 1.7%
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2.1. Study area
Gadarif State is one of the most important states in Sudan
and plays a signiﬁcant role in the economic and agricultural
activities of the country. It has a population of 1 727 401 resi-
dents, covers 75 000 km2, and lies between latitude 14 and
16 north and longitude 33 and 36 east. The average rainfall
is 612 /millimeter. Four rivers pass through the state (Atbara,
Elrahad, Saitit, and Basalam) and there are many forests, which
provide an excellent environment for the sand ﬂy vector. There
are 10 centers for the diagnosis and treatment of VL in the
State.
2.2. Study design
To investigate the cumulative number of cases, case fatality
rate, and trend in the incidence and mortality rate of VL, a
retrospective descriptive study was performed through an analysis
of the database managed by the Ministry of Health of Gadarif State,
which includes all cases of VL. This database is based on
registration at the Department of Infectious Diseases of the
Ministry of Health, Gadarif State, Eastern Sudan. The data include
personal and social information, the clinical presentation, type of
leishmaniasis, follow-up, and the outcome. The outcome is
registered as complete recovery, relapse, lost during follow-up,
or death; death is registered without further explanation (disease-
related or not disease-related). All cases reported during a 14-year
period (January 1, 2002 through December 31, 2015) were
collected. For each case, the following data were retrieved: sex,
age, residence, occupation, and outcome. In accordance with the
Sudanese health system, patients aged 18 years were considered
children.
2.3. Patient management
According to the World Health Organization (WHO), a case of
visceral leishmaniasis is a person showing clinical signs of the
disease (mainly prolonged irregular fever, splenomegaly, and
weight loss) and with conﬁrmation, based mainly on bone
marrow aspiration, through direct microscopic visualization or
PCR detection.10 The WHO guidelines were applied for all
identiﬁed leishmaniasis patients; these guidelines are based on
the internationally agreed strategies for the control of the
disease.6 The recommended treatment regimen in Sudan
consists of intravenous sodium stibogluconate 20 mg/kg plus
intramuscular paromomycin 15 mg/kg for 17 days as the ﬁrst-
line therapy. In cases with severe side effects, liposomal
amphotericin B (Ambisome 3 mg/kg for 10 days) is the second
option.
2.4. Analysis
Data were entered into a computer database and SPSS version
16.0 software (SPSS Inc., Chicago, IL, USA) and double-checked
before analysis. Trends in the incidence rates and mortality
were analyzed by linear regression. Means and proportions of the
socio-demographic characteristics were compared between
the study groups (patients who died and those who survived),
and p < 0.05 was considered signiﬁcant.
2.5. Ethics
The study received ethical clearance from the Research Board
Committee, Gadarif University.3. Results
3.1. General characteristics
During the 14-year study period (2002–2015), a total of
51 773 patients were registered in Gadarif State with clinical and
laboratory evidence of proven VL. Their mean age was 24.1
(standard deviation 18) years. The majority of these patients had
less than a secondary level of education (49 201, 95%), were male
(37 002, 71.4%), and lived in a rural area (35 611, 68.7%). More
than half of the study sample were adults (29 183 adults (56.4%)
and 22 590 children (43.6%)). With regard to environmental
factors, the majority of the adult study subjects were farmers
(75.2%); housewives made up the lowest percentage (7.7%). Out of
the 51 773 VL cases, 48 395 (93.5%) recovered completely, 1686
(3.3%) died, 1581 (3%) relapsed, and 111 (0.2%) were lost during
follow-up.
3.2. Cumulative number of cases and fatality rate
Table 1 shows the cumulative number of cases and the case
fatality rates. The highest fatality rate was observed in the year
2002 (4.8%); this rate had declined in 2014 (1.1%) and 2015 (1.7%)
(Figure 2).
3.3. Trend in VL
As seen in Figure 1, the trend in VL was considerably higher over
the years 2003–2005 as compared to the last 5 years of 2011–2015.
There were three incidence peaks at different intervals (2003,
2010, and 2014).
3.4. Socio-demographic factors associated with death related to VL
With regard to the socio-demographic factors associated with
death related to VL, this study revealed that there was no
signiﬁcant difference in age, education level, or sex between those
who died and those who survived. However residence in a rural
area was statistically associated with death related to VL
(p = 0.021) (Table 2).
4. Discussion
This study provides a 14-year review of the epidemiological
trends and patient characteristics of leishmaniasis in Eastern
Sudan. This appears to be the largest report of VL for the country.
The main ﬁnding of this study was the high number of cumulative
cases of VL in Eastern Sudan. There was a clear decline in the
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Figure 2. Case fatality rate of visceral leishmaniasis in Gadarif State, Eastern
Sudan—2002–2015.
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Figure 1. Annual incidence of visceral leishmaniasis in Gadarif State, Eastern
Sudan—2002–2015.
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observed to be more prevalent among adults and males, and the
number of deaths was higher among those living in a rural area.
This indicates that Gadarif State is an area endemic for
leishmaniasis. The disease is also endemic in neighboring countries
bordering Sudan, including Ethiopia, Kenya, and South Sudan.11
The current study showed three incidence peaks at different
intervals (2003, 2010, and 2014). The variation in the number of
cumulative cases of VL and the incidence peaks may be due to the
variations in rainfall during the study period. The difference in
rainfall is a factor recognized to be associated with a person’s
vulnerability to infection.
This study showed that the case fatality rates were higher in the
ﬁrst 9 years and declined in 2011–2015. This could be due to
patient awareness, the adoption of new treatment guidelines, the
introduction of nutritional supplements for all kala-azar patients,
and the expansion of treatment facilities, among others.
In line with the present results, VL has been shown to be more
prevalent among males in many reports and this is explained by
the greater exposure of males than females to the sand ﬂy vector
due to differences in occupation.12,13 The present study showed
that males were affected more than females, a result which is in
line with the ﬁndings of Sordo et al.14 In agreement with the
present study, Custodio et al. and Perry et al. revealed that VL
infection is more common in boys than in girls.15,16 Furthermore,
in neighboring Ethiopia, Ali et al. and Alvar et al. reported that the
majority of VL cases occur in males, a pattern caused by increased
exposure to the sand ﬂy vector during agricultural work and other
work in the ﬁeld.3,17 The association between rural residence and
death related to VL may be attributed to poverty, low immunity,
food insecurity, malnutrition, and limited access to treatment
services and thus late presentation.Table 2
Socio-demographic characteristics and death related to visceral leishmaniasis in
Gadarif State, Eastern Sudana
Variable Recovered
completely
(n = 48 395)
Died
(n = 1686)
Relapsed
(n = 1581)
Lost
(n = 111)
p-Value
Age, years 29.0  5.6 28.1  9.5 28.4  6.3 28.1  5.9 0.131
Education
less than
secondary
level
46 020 (95) 1580 (93.7) 1500 (94.8) 101 (90.9) 0.128
Sex, male 33 952 (70) 1518 (90.3) 1433 (90.6) 99 (89.1) 0.111
Rural
residence
32 671 (67.5) 1670 (99) 1210 (76) 60 (54) 0.021
Adult 27 696 (57.2) 689 (40.8) 711 (44.9) 87 (78.3) 0.201
a Data are reported as the mean  standard deviation, or number (percentage), as
applicable.One of the major limitations of this study is that the nutritional
status and socio-economic status were not assessed due to
logistical constraints. Also there were no data available on HIV
or other co-infections with VL. Therefore it is necessary to conduct
studies to investigate whether the patient’s nutritional status or
socio-economic status predisposes them to VL infection and
whether these constitute a risk factor for death related to VL.
In conclusion, this study showed a high number of cumulative
cases of VL in Eastern Sudan. The vast majority of infected people
were male and adult. The fatality rate was highest among rural
residents, and it declined over the last 5 years of the study. Thus
immediate interventions are needed in terms of health education
and the implementation of preventive measures, with a speciﬁc
focus on people living in rural areas.
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